Point-of-care, also known as point-of-need, has proved to be a key term over the last decade, and it refers to a qualitative (and sometimes also quantitative) analytical statement that is arrived at with as few equipment arrays as possible and no specimen preparation. It is still primarily associated with the medical sector, specifically for measuring blood sugar levels. However, a growing number of other point-of-care measurements are entering the market, such as the measurement of specific environmental parameters and water quality, food monitoring or (epidemic) prevention, to name just a few areas.
The Fraunhofer IZI-BB develops and works on a range of concepts and technologies in the point-of-care area. Along with the development of new diagnostic methods, the institute offers its customers and partners the transfer of existing tests (e.g. ELISAs, DNA microarrays, etc.) to a miniaturized format. For example, an in-vitro diagnostics (ivD) platform is available for this, which can be adapted for different diagnostic tests according to the area of inquiry.